BOK Financial Private Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $232K | Sell |
8,275
-70
| -0.8% | -$1.86K | 0.01% | 171 |
|
|
2025
Q4 | $208K | Sell |
8,345
-450
| -5% | -$11.3K | 0.01% | 179 |
|
|
2025
Q3 | $224K | Hold |
8,795
| – | – | 0.01% | 167 |
|
|
2025
Q2 | $213K | Hold |
8,795
| – | – | 0.01% | 172 |
|
|
2025
Q1 | $223K | Sell |
8,795
-5,071
| -37% | -$133K | 0.02% | 165 |
|
|
2024
Q4 | $368K | Sell |
13,866
-706
| -5% | -$19.1K | 0.03% | 142 |
|
|
2024
Q3 | $422K | Buy |
14,572
+1,298
| +10% | +$37.9K | 0.03% | 141 |
|
|
2024
Q2 | $371K | Sell |
13,274
-558
| -4% | -$15.4K | 0.03% | 143 |
|
|
2024
Q1 | $384K | Buy |
13,832
+558
| +4% | +$15.5K | 0.03% | 144 |
|
|
2023
Q4 | $382K | Sell |
13,274
-69
| -0.5% | -$2.09K | 0.03% | 137 |
|
|
2023
Q3 | $443K | Buy |
13,343
+988
| +8% | +$34.9K | 0.04% | 128 |
|
|
2023
Q2 | $453K | Buy |
12,355
+491
| +4% | +$19.1K | 0.04% | 128 |
|
|
2023
Q1 | $484K | Buy |
11,864
+31
| +0.3% | +$1.34K | 0.04% | 132 |
|
|
2022
Q4 | $606K | Sell |
11,833
-6,131
| -34% | -$294K | 0.05% | 121 |
|
|
2022
Q3 | $786K | Sell |
17,964
-472
| -3% | -$22.9K | 0.07% | 110 |
|
|
2022
Q2 | $967K | Sell |
18,436
-22,111
| -55% | -$1.13M | 0.09% | 107 |
|
|
2022
Q1 | $2.1M | Sell |
40,547
-735
| -2% | -$38.1K | 0.15% | 94 |
|
|
2021
Q4 | $2.44M | Buy |
41,282
+14,309
| +53% | +$709K | 0.17% | 87 |
|
|
2021
Q3 | $1.16M | Buy |
26,973
+4,246
| +19% | +$188K | 0.09% | 103 |
|
|
2021
Q2 | $890K | Buy |
22,727
+3,806
| +20% | +$148K | 0.07% | 112 |
|
|
2021
Q1 | $686K | Sell |
18,921
-74
| -0.4% | -$2.63K | 0.06% | 113 |
|
|
2020
Q4 | $699K | Buy |
18,995
+2,237
| +13% | +$82.1K | 0.07% | 108 |
|
|
2020
Q3 | $583K | Sell |
16,758
-638
| -4% | -$22.4K | 0.06% | 111 |
|
|
2020
Q2 | $540K | Sell |
17,396
-911
| -5% | -$30.9K | 0.06% | 114 |
|
|
2020
Q1 | $567K | Sell |
18,307
-17,682
| -49% | -$603K | 0.07% | 121 |
|
|
2019
Q4 | $1.34M | Buy |
35,989
+21,016
| +140% | +$749K | 0.11% | 89 |
|
|
2019
Q3 | $510K | Sell |
14,973
-987
| -6% | -$35.9K | 0.07% | 66 |
|
|
2019
Q2 | $656K | Buy |
15,960
+1,281
| +9% | +$50.9K | 0.1% | 59 |
|
|
2019
Q1 | $591K | Buy |
14,679
+141
| +1% | +$5.65K | 0.08% | 57 |
|
|
2018
Q4 | $602K | Buy |
14,538
+4,134
| +40% | +$172K | 0.08% | 60 |
|
|
2018
Q3 | $435K | Hold |
10,404
| – | – | 0.07% | 59 |
|
|
2018
Q2 | $358K | Sell |
10,404
-11,594
| -53% | -$396K | 0.06% | 60 |
|
|
2018
Q1 | $741K | Sell |
21,998
-275
| -1% | -$9.45K | 0.12% | 45 |
|
|
2017
Q4 | $765K | Buy |
22,273
+157
| +0.7% | +$5.35K | 0.12% | 48 |
|
|
2017
Q3 | $749K | Sell |
22,116
-6,160
| -22% | -$198K | 0.12% | 51 |
|
|
2017
Q2 | $901K | Sell |
28,276
-7,940
| -22% | -$250K | 0.13% | 46 |
|
|
2017
Q1 | $1.18M | Buy |
36,216
+3,171
| +10% | +$100K | 0.17% | 42 |
|
|
2016
Q4 | $1.02M | Buy |
33,045
+1,581
| +5% | +$48.3K | 0.15% | 48 |
|
|
2016
Q3 | $1.01M | Sell |
31,464
-99
| -0.3% | -$3.31K | 0.15% | 44 |
|
|
2016
Q2 | $1.05M | Buy |
31,563
+7,726
| +32% | +$247K | 0.17% | 42 |
|
|
2016
Q1 | $670K | Buy |
23,837
+527
| +2% | +$15.1K | 0.11% | 34 |
|
|
2015
Q4 | $714K | Hold |
23,310
| – | – | 0.12% | 32 |
|
|
2015
Q3 | $695K | Buy |
23,310
+3,162
| +16% | +$101K | 0.12% | 32 |
|
|
2015
Q2 | $641K | Sell |
20,148
-1,054
| -5% | -$34.4K | 0.11% | 35 |
|
|
2015
Q1 | $700K | Hold |
21,202
| – | – | 0.12% | 34 |
|
|
2014
Q4 | $627K | Hold |
21,202
| – | – | 0.1% | 40 |
|
|
2014
Q3 | $595K | Hold |
21,202
| – | – | 0.1% | 38 |
|
|
2014
Q2 | $597K | Sell |
21,202
-475
| -2% | -$13.5K | 0.1% | 38 |
|
|
2014
Q1 | $661K | Hold |
21,677
| – | – | 0.12% | 36 |
|
|
2013
Q4 | $630K | Buy |
21,677
+597
| +3% | +$17.4K | 0.11% | 34 |
|
|
2013
Q3 | $575K | Buy |
21,080
+12,648
| +150% | +$344K | 0.12% | 34 |
|
|
2013
Q2 | $224K | Buy |
+8,432
| New | +$233K | 0.05% | 47 |
|
Other funds holding PFE
VCM
VPM
BOK Financial Private Wealth's PFE Position: Q1 2026 in Review
BOK Financial Private Wealth reduced its Pfizer (PFE) stake by 0.84% in Q1 2026, selling an estimated $1.86K and leaving 8,275 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #171.
BOK Financial Private Wealth first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.44M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- BOK Financial Private Wealth held 8,275 shares of Pfizer worth $232K as of Q1 2026.
- BOK Financial Private Wealth sold 70 Pfizer shares in Q1 2026, an estimated $1.86K.
- Pfizer made up 0.01% of BOK Financial Private Wealth's portfolio in Q1 2026, its #171 holding.
- BOK Financial Private Wealth first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- BOK Financial Private Wealth's Pfizer position peaked at $2.44M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.